欧盟HMA药品数据库（European Union HMA Authorisation of Medicines DataBase）

MR编号	NL/H/0423/003
药品名称	Ceftriaxon Sandoz 2
活性成分	ceftriaxone disodium 2.0 g
剂型	Powder for solution for injection
上市许可持有人	Sandoz B.V. Veluwezoom 22 1327 AH Almere The Netherlands
参考成员国 - 产品名称	Netherlands (NL) Ceftriaxon Sandoz 2, poeder voor oplossing voor injectie/infusie 2 g
互认成员国 - 产品名称	United Kingdom (Northern Ireland) (XI) Austria (AT) Ceftriaxon Sandoz 2 g - Trockenstechampulle Germany (DE) Ceftriaxon Sandoz 2 g Pulver zur Herstellung einer Injektions- oder Infusionslösung Denmark (DK) Ceftriaxon "Sandoz" Italy (IT) Finland (FI) Poland (PL) Lendacin Hungary (HU) Ceftriaxion-Sandoz por inj. Slovakia (SK) Ceftriaxon Sandoz 2 g prášok na infúzny roztok Slovenia (SI) Belgium (BE)
许可日期	2003/11/18
最近更新日期	2021/12/28
药物ATC编码	J01DD04 ceftriaxone
申请类型	TypeLevel1：Abridged TypeLevel2：Initial Application TypeLevel3：Generic Article 4.8(a)(iii), first paragraph TypeLevel4：Chemical Substance TypeLevel5：Prescription Only
附件文件下载	Final PL \| common-spc ceftriaxon sandozDate of last change:2021/11/11 Final PL \| common-pl ceftriaxon sandozDate of last change:2021/11/11 Final SPC \| common-spcDate of last change:2021/04/26 Final Product Information \| 1.3.1 spc-label-pl - common-pl - 8,391Date of last change:2017/09/12 Final Product Information \| 1.3.1 spc-label-pl - common-outer - 3,279Date of last change:2017/09/12 Final Product Information \| 1.3.1 spc-label-pl - common-outer - 3,280Date of last change:2017/09/12 Final Product Information \| 1.3.1 spc-label-pl - common-SPC - 2,719Date of last change:2017/09/12 Final Product Information \| 1.3.1 spc-label-pl - common-pl - 8,392Date of last change:2017/09/12 Final Product Information \| 1.3.1 spc-label-pl - common-SPC - 2,718Date of last change:2017/09/12 Final Labelling \| Labelling NL_H_0423Date of last change:2013/09/13
市场状态	Positive